Filing Details
- Accession Number:
- 0001209191-15-007127
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-28 17:54:35
- Reporting Period:
- 2015-01-26
- Filing Date:
- 2015-01-28
- Accepted Time:
- 2015-01-28 17:54:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1423824 | Alder Biopharmaceuticals Inc | ALDR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1604874 | A John Latham | 11804 North Creek Parkway South Bothell WA 98011 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-26 | 7,900 | $0.39 | 216,888 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-26 | 7,900 | $27.98 | 208,988 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-01-27 | 7,145 | $0.39 | 216,133 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-01-27 | 7,145 | $28.73 | 208,988 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2015-01-26 | 60,000 | $0.00 | 60,000 | $28.23 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-01-26 | 7,900 | $0.00 | 7,900 | $0.39 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-01-27 | 7,145 | $0.00 | 7,145 | $0.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 60,000 | 2025-01-25 | No | 4 | A | Direct | |
| 92,100 | 2016-09-14 | No | 4 | M | Direct | |
| 84,955 | 2016-09-14 | No | 4 | M | Direct |
Footnotes
- The exercise of options reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2014.
- Includes 504 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on November 28, 2014.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.97 to $28.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 4 to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.11 to $30.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 5 to this Form 4.
- The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of the vesting commencement date and 1/48th of the total number of shares each monthly anniversary of the vesting commencement date thereafter, for so long as the recipient of the option provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the vesting commencement date.
- The option was fully vested.
Billionaire Hedge Funds
